The pharmaceutical Ipsen group announced the beginning of use of platform 3DExperience

The Ipsen company selected industry solution of 'Designed to Cure' for acceleration of transformation of the research direction and also for search and development of new medicinal solutions. The platform provides abilities to integrate data, modeling and simulation of processes for receiving a better understanding about the violations connected with different diseases. Besides, the platform facilitates and accelerates process of search of more effective potential medicines. This project is designed to optimize processes of research and development in Ipsen, work on which is carried out by the numerous teams of specialists of a different profile which are based in biotechnology clusters in France, Great Britain and in the USA and also a global network of partners in development of medicines, including, scientists of a world class, the biotechnology companies, the organizations which are engaged in clinical trials, and other concerned parties.

"Ipsen cooperates already more than five years with Dassault Systèmes over the BioIntelligence project. We are glad to a new important step in our partnership – to implementation of this advanced complex of the innovation tools, – Claude Bertrand, the executive vice president for researches and developments and the chief researcher in Ipsen says. – Open innovations – in DNA of Ipsen company as our key partner in scientific research; this innovation digital platform for joint work will support commitment of Ipsen in development of revolutionary therapeutic solutions for treatment of patients".